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Syphilis is a preventable and curable multi-organ disease caused by Treponema pallidum that may also aﬀect the inner ear. First
reported in 1887 by Adam Politzer, luetic endolymphatic hydrops (LEH) is a treatable complication of syphilis which causes a
potentiallyreversiblesensorineuralhearingloss.SymptomsofLEHincludeﬂuctuatinghearingloss(oftenlowfrequency),tinnitus,
and vertigo. Though audiometric parameters have been examined in patients with otosyphilis, few studies have examined the use
of otoacoustic emissions (OAEs) as a tool to measure improvement in cochlear function. Here we report an improvement in
hearing loss, speech discrimination, and OAEs following treatment of LEH.
Copyright © 2009 Robert H. Chun et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Since 2000, the incidence of primary and secondary syphilis
in the U.S. has been increasing. During 2005-2006, the
number of cases reported to CDC increased 12.4% for early
latent syphilis (from 8176 to 9186), 9.9% for late and late
latent syphilis (from 16049 to 17644), and 11.0% for the
total number of cases of syphilis (P&S, early latent, late, late
latent, and congenital syphilis) (from 33288 to 36935) [1].
Among males, the rate of primary and secondary syphilis
has risen 70% over the past ﬁve years. Among females, the
rate of primary and secondary syphilis increased 11.1% from
2005-2006. Thus, with an increasing national rate, syphilis
and its subsequent complications represent an important
consideration in the evaluation of neuro-otologic disease.
Unlike primary idiopathic hydrops, treatment of LEH
with steroids and antibiotics often reverses the symptoms. In
a study by Lindstrom and Cleich, treatment of otosyphilis
with penicillin and steroids caused an improvement in hear-
ing (speech reception threshold and/or speech discrimina-
tion in 25%), decrease in tinnitus (71%), and improvement
in disequilibrium in 66% of their patients [2]. Amenta and
Dayal found that the most obvious improvement in cases of
treated LEH is the speech discrimination score [3]. However,
improvement in cochlear function has not been described in
the treatment of LEH.
Case Presentation. A 42-year-old female presented with
complaints of hearing loss in her left ear for 2-3 months with
occasional bilateral tinnitus. Prior to treatment, standard
behavioral audiometry (250–8000Hz) was obtained (Fig-
ure 1), as well as distortion product otoacoustic emissions
(DPOAEs). DPOAEs were tested using Bio-logic Systems
Corp. Scout Otoacoustic Emissions Testing System, software
version 3.45.00, diagnostic protocols. Pretreatment results
for the patient’s right ear indicated moderate to mild
sensorineural hearing loss, andthe leftearrevealedprofound
tomoderatemixedhearingloss(leftboneconductionsimilar
to right bond responses). Speech discrimination scores were
good in the right ear, 84% at 50dBHL; poor in the left ear,
60% at 85dBHL. DPOAE testing revealed distortion product
minusnoiseﬂoorwas>5dBforonly15%ofmeasuredpoints
(750–8000Hz) in the right ear and 32% in the left ear.2 International Journal of Otolaryngology
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Figure 1: Audiogram prior to treatment.
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Figure 2: Audiogram following treatment.
Laboratory testing included collagen proﬁle test, RPR,
and ﬂuorescent treponemal antibody absorption (FTA-ABS)
test. Results revealed the patient’s RPR and ﬂuorescent
treponemal antibody absorption test to be positive. Fur-
thermore, a history of syphilis was conﬁrmed. Following a
course of 2.4 million units of Benzathine Penicillin G and
Prednisone for three weeks, the patient reported improve-
ment in hearing. Repeat audiologic evaluation obtained one
month after diagnosis revealed improved hearing (Figure 2),
and interestingly, the patient’s DPOAEs recovered following
treatment. Posttreatment results revealed improved left
ear responses (mild, ﬂat sensorineural hearing loss with
moderate conductive component at 500–1000Hz). Speech
discrimination improved to 92% in the right ear and 96%
in the left ear (both presented at 75 dBHL). Posttreatment
DPOAEs were measured (2000–8000Hz) and revealed right
ear distortion product minus noise ﬂoor was >5dB for
93% of measured points (range 5.1–15.6dB) and left ear
86% (range 6.3–15.5dB), reﬂecting a recovery of cochlear
function. The patient continues to show recovery of both
hearing and OAEs nearly one year from treatment.
2. Discussion
Syphilis is a multisystem disease that can aﬀect the inner
ear. Patients with LEH may present with tinnitus, ﬂuctuating
hearing loss with poor speech discrimination, episodic ver-
tigo,andnystagmus[3].LEHmanifestsduringthelatestages
of congenital or acquired syphilis. It is known that syphilis
within the temporal bone causes a round cell inﬁltration
with endarteritis, resulting in tissue destruction involving
any or all of the periosteum, periosteal bone, enchondral
bone, and endosteum. With penetration of the endosteum,
there is a proliferative ﬁbrosis with obliteration of the
perilymphatic space, cochlear hydrops and degeneration of
the neuroepithelium of both the cochlear and vestibular end
organs [4].
OAEs are believed to be a measurement of outer hair cell
function and to be a by-product of the cochlear ampliﬁer,
a metabolic mechanism that enhances cochlear partition
vibration during transmission of sound through the hearing
system[5,6].RecoveredOAEsinthispatientstronglysuggest
that OAEs may serve as a tool to measure cochlear function
and serve as a treatment outcome for LEH.
Inthispatient,therewasbothanimprovementinhearing
loss as well as recovery of OAE following treatment. This
reversal of OAE loss suggests that injury to outer hair cell
function and the cochlear ampliﬁer are reversible entities
in this disease. We suggest that OAE testing can be used to
monitor response to treatment of LEH. Further studies may
be indicated to assess the sensitivity and speciﬁcity of OAE
testing as a therapeutic measurement.
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